Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrea Wirsching is active.

Publication


Featured researches published by Andrea Wirsching.


British Journal of Surgery | 2016

Meta‐analysis of associating liver partition with portal vein ligation and portal vein occlusion for two‐stage hepatectomy

Dilmurodjon Eshmuminov; Dimitri Aristotle Raptis; Michael Linecker; Andrea Wirsching; Mickael Lesurtel; P.-A. Clavien

Discussion is ongoing regarding whether associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion is better in staged hepatectomy. The aim of this study was to compare available strategies using a two‐stage approach in extended hepatectomy.


British Journal of Surgery | 2015

Epidural analgesia and perioperative kidney function after major liver resection.

P. Kambakamba; K. Slankamenac; C. Tschuor; P. Kron; Andrea Wirsching; K. Maurer; Henrik Petrowsky; P.-A. Clavien; Mickael Lesurtel

Epidural analgesia (EDA) is a common analgesia regimen in liver resection, and is accompanied by sympathicolysis, peripheral vasodilatation and hypotension in the context of deliberate intraoperative low central venous pressure. This associated fall in mean arterial pressure may compromise renal blood pressure autoregulation and lead to acute kidney injury (AKI). This study investigated whether EDA is a risk factor for postoperative AKI after liver surgery.


Surgery | 2017

Temporary portal vein embolization is as efficient as permanent portal vein embolization in mice

Andrea Wirsching; Emmanuel Melloul; Ksenia Lezhnina; Anton Buzdin; Omolara O. Ogunshola; Pieter Borger; Pierre-Alain Clavien; Mickael Lesurtel

Background. Temporary portal vein embolization may be a safe alternative to permanent portal vein embolization. Such a new approach could be applied in living‐related liver transplantation to increase graft volume before procurement. The impact of temporary portal vein embolization on occluded liver after recanalization, however, has never been assessed. Using a mouse model of temporary portal vein embolization, we investigated (1) the efficiency of temporary portal vein embolization in inducing nonoccluded liver hypertrophy and (2) the regeneration potential and functional recovery of embolized liver after recanalization. Methods. Selected portal vein branches were occluded using gelfoam powder (temporary portal vein embolization) or embospheres (permanent portal vein embolization), n = 5/group. Magnetic resonance volumetry and angiography were used to determine volumes of the liver lobe and portal vein branch recanalization. In order to assess the functional and regenerative capacity of occluded liver lobes, nonoccluded lobes were resected 14 days (timespan of complete portal vein recanalization) after temporary portal vein embolization or permanent portal vein embolization. Subsequently, RNA sequencing was performed to compare the signaling pathways of early liver regeneration among the groups. Results. Hypertrophy of nonoccluded lobes 30 days after temporary portal vein embolization and permanent portal vein embolization was similar (103 ± 26% and 129 ± 13%, P = .11). Temporary occluded lobes increased their volumes after nonoccluded lobes resection, reaching similar liver‐to‐body‐weight ratios and similar functional capacity after 7 days compared with partial hepatectomy controls (4 ± 1% vs 4 ± 1%, P = .22). Partial hepatectomy activated similar signaling pathways in temporary occluded and native liver. Conclusion. Temporary portal vein embolization induces hypertrophy of contralateral liver lobes similarly to permanent portal vein embolization in mice. This experimental work suggests that temporary portal vein embolization may be considered as a possibility in living liver donation, because regenerative and functional capacities are preserved in the embolized liver after recanalization in mice.


PLOS ONE | 2018

Prediction of small for size syndrome after extended hepatectomy: Tissue characterization by relaxometry, diffusion weighted magnetic resonance imaging and magnetization transfer

Christian Eberhardt; Moritz C. Wurnig; Andrea Wirsching; Cristina Rossi; Idana Feldmane; Mickael Lesurtel; Andreas Boss

This study aimed to monitor the course of liver regeneration by multiparametric magnetic-resonance imaging (MRI) after partial liver resection characterizing Small-for-Size Syndrome (SFSS), which frequently leads to fatal post-hepatectomy liver failure (PLF). Twenty-two C57BL/6 mice underwent either conventional 70% partial hepatectomy (cPH), extended 86% partial hepatectomy (ePH) or SHAM operation. Subsequent MRI scans on days 0, 1, 2, 3, 5 and 7 in a 4.7T MR Scanner quantified longitudinal and transverse relaxation times, apparent diffusion coefficient (ADC) and the magnetization-transfer ratio (MTR) of the regenerating liver parenchyma. Histological examination was performed by hematoxylin-eosin staining. After hepatectomy, an increase of T1 time was detected being larger for ePH on day 1: 18% for cPH vs. 40% for ePH and on day 2: 24% for cPH vs. 49% for ePH. An increase in T2 time, again greater in ePH was most pronounced on day 5: 21% for cPH vs. 41% for ePH. ADC and MTR showed a decrease on day 1: 21% for ePH vs. 13% for cPH for ADC, 15% for ePH vs. 11% for cPH for MTR. Subsequently, all MR parameters converged towards initial values in surviving animals. Dying PLF animals exhibited the strongest increase of T1 relaxation time and most prominent decreases of ADC and MTR. The retrieved MRI biomarkers indicate SFSS and potentially developing PLF at an early stage, likely reflecting cellular hypertrophy with extended water content and concomitantly diluted cellular components as features of liver regeneration, appearing more intense in ePH as compared to cPH.


BMC Gastroenterology | 2015

“A randomized, double-blind study of the effects of omega-3 fatty acids (Omegaven™) on outcome after major liver resection”

Michael Linecker; Perparim Limani; Florin Botea; Irinel Popescu; R. Alikhanov; Michail Efanov; P. Kim; Igor Khatkov; Dimitri Aristotele Raptis; Christoph Tschuor; Beatrice Beck-Schimmer; John M. Bonvini; Andrea Wirsching; Philipp Kron; Ksenija Slankamenac; Bostjan Humar; Rolf Graf; Henrik Petrowsky; Pierre-Alain Clavien


Magnetic Resonance Materials in Physics Biology and Medicine | 2016

Intravoxel incoherent motion analysis of abdominal organs: computation of reference parameters in a large cohort of C57Bl/6 mice and correlation to microvessel density

Christian Eberhardt; Moritz C. Wurnig; Andrea Wirsching; Cristina Rossi; Markus Rottmar; Pinar Senay Özbay; Lukas Filli; Mickael Lesurtel; Andreas Boss


Journal of The American College of Surgeons | 2017

Pathologic High-Resolution Manometry Findings Are Not Necessarily Associated with Inferior Outcomes after Paraesophageal Hernia Repair

Andrea Wirsching; Qing Zhang; Susan E. McCormick; Michal Hubka; Donald E. Low


Gastroenterology | 2017

Early Mri-Based Liver Fat Quantificationpredicts Outcome After Extended Hepatectomy in Mice

Andrea Wirsching; Christian Eberhardt; Moritz C. Wurnig; Andreas Boss; Mickael Lesurtel


Gastroenterology | 2017

Interdisciplinary Reporting of Outcomes: A Meta-Analysis of Definitive Chemoradiation vs. Surgery for Esophageal Cancer

Andrea Wirsching; Sheraz R. Markar; Mustapha El Lakis; Donald E. Low


Gastroenterology | 2017

Outcomes Following Acute vs. Elective Paraesophageal Hernia Repair:Emergency Surgery is Only Selectively Required in Patients with Acute Presentation

Andrea Wirsching; Mustapha El Lakis; Kamran Mohiuddin; Michal Hubka; Donald E. Low

Collaboration


Dive into the Andrea Wirsching's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donald E. Low

Virginia Mason Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge